Table 3.
miRNA | Cancer type | Chemotherapy agent | Notes and suggestive target effect | References |
---|---|---|---|---|
miR-199a-5p, miR-302f, miR-320a, miR-342-3p, miR-425, miR-455-3p, miR-486-3p, miR-519c-5p, miR-548d-5p, miR-617, miR-758, miR-766, miR-1286 | Esophageal carcinoma cell lines | Cisplatin or 5-fluorouracil | Cellular response to a cytotoxic stimulus | 62 |
miR-125b | Breast cancer | Taxane-anthracycline | Validated protein targets of miR-125b are involved in apoptotic pathways and cell cycle control | 65 |
miR-122a, miR-145 and miR-205 | MDA-MB-453 triple-negative breast cancer cells | Capecitabine and ixabepilone | - | 66 |